David Kimhy.jpg

Communication Officer

David Kimhy, PhD  is an Associate Professor, the Director of the Experimental Psychopathology Laboratory, and the Program Leader for New Interventions in Schizophrenia at the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai. He also serve as a Research Scientist at the Mental Illness Research, Education, and Clinical Center (MIRECC) at the James J. Peters VA Medical Center in The Bronx, NY. Prior to joining Mount Sinai in 2017, he was on faculty at Columbia University and the New York State Psychiatric Institute. Over the past decade, Dr. Kimhy served as a Beck Institute Scholar at the Beck Institute for Cognitive Therapy and Research and is a senior faculty at the Institute of Cognitive Therapy for Psychosis (ICTP), an institution dedicated to CBTp training and dissemination. Dr. Kimhy’s research center on two primary areas: 1) The use of translational approaches to elucidate the mechanisms of development and recovery from psychopathology in individuals with schizophrenia and at-risk for psychosis; and 2) The development and dissemination of cognitive and behavioral interventions to improve cognitive, affective, and social functioning. Dr. Kimhy served as a PI on multiple grants (R01, K23, R21, T32) funded by the National Institute of Mental Health (NIMH) and the National Alliance for Research of Schizophrenia and Affective Disorders (NARSAD).